| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 65,662 | 62,889 | 60,491 | 62,254 | | Cost of Revenue | 30,843 | 29,231 | 27,981 | 30,263 | | | Gross Profit | 34,819 | 33,658 | 32,510 | 31,991 | | | Operating Expenses | | Research Development | 7,407 | 6,612 | 6,454 | 5,967 | | Selling General and Administrative | 24,043 | 23,599 | 24,534 | 24,786 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 3,369 | 3,447 | 1,522 | 1,238 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 330 | 60 | 115 | 1,090 | | Earnings Before Interest And Taxes | 3,699 | 3,507 | 1,637 | 2,328 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 3,699 | 3,507 | 1,637 | 2,328 | | Income Tax Expense | 1,005 | 1,326 | 627 | (7,706) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,694 | 2,181 | 1,010 | 10,034 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,694 | 2,181 | 1,010 | 10,034 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $2,694 | $2,181 | $1,010 | $10,034 |
|
0.03% Nasdaq 
Income Statement
